Corona virus 8/30/20 - Preventive Medicine Center

8/6/20: N Potere “Disease progression was experienced by none of the (low dose) tocilizumb-treated patients vs by 5 (50%) patients in the standard of care group. Overall, experts concluded that in hospitalized patients with moderate COVID-19 and hyperinflammation.” “Immune Boosting Role of Vitamins” Maturitas. 8/10/20 H Shakoor. ................
................